Guardian Pharmacy Services, Inc. ("Guardian") (NYSE: GRDN) today announced the pricing of its upsized underwritten public offering (the "Offering") of 6,000,000 shares of its Class A common stock at a ...

After more than 15 years of setbacks, Mesoblast has finally secured its first FDA approval, and early signs suggest the ... Read More The post Dr Boreham’s Crucible: The long grind finally pays off ...

Following the patent expiry of Novo Nordisk’s semaglutide on March 20, 2026, Indian drugmakers including Natco, Dr. Reddy’s, and Eris are launching generic versions at 70-90% discounts.

Half of US generic drugs are made in India and transit the Strait of Hormuz. Supply chains prepare for emergencies, but prescription stockpiles are limited.

Foreign substances, including black particles and a gel-like mass, were reportedly found in the over-the-counter children's ...

Biotech stocks surged in 2025, driven by FDA approvals, M&A activity, and rising longevity investment. Explore key trends, top-performing sectors, and what’s next for biotech investors.

Novo Nordisk’s 7.2 mg dose of Wegovy will compete against Lilly’s GLP-1 injection.

This trend affects workers and customers alike and can, in part, explain a whole array of elements that have made American ...

Monte Rosa Therapeutics (NasdaqGS:GLUE) announced a new supply agreement with Johnson & Johnson to evaluate MRT-2359 with ERLEADA in metastatic castration resistant prostate cancer. The company is ...

A pastor who hosts races on TikTok. Gearheads who customize for profit. A private collector with a museum full of prototypes.

Juliette Kenny’s father wants his daughter’s legacy to be improved access to the menB vaccination for teenagers and young people ...

Two people — an 18-year-old sixth form student, Juliette Kenny, and a 21-year-old University of Kent student — have died, as the total number of confirmed and suspected cases has risen to 20, ...